188 related articles for article (PubMed ID: 22632751)
21. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.
Urbanska AM; Zhang X; Prakash S
Cell Biochem Biophys; 2015 Jul; 72(3):757-69. PubMed ID: 27352189
[TBL] [Abstract][Full Text] [Related]
22. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer.
Li Y; de Haar C; Peppelenbosch MP; van der Woude CJ
Cytokine Growth Factor Rev; 2012 Jun; 23(3):127-38. PubMed ID: 22591635
[TBL] [Abstract][Full Text] [Related]
23. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
Koehler BC; Jassowicz A; Scherr AL; Lorenz S; Radhakrishnan P; Kautz N; Elssner C; Weiss J; Jaeger D; Schneider M; Schulze-Bergkamen H
BMC Cancer; 2015 Nov; 15():919. PubMed ID: 26585594
[TBL] [Abstract][Full Text] [Related]
24. SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKIIγ/AKT-mediated pathway.
Jing Z; Sui X; Yao J; Xie J; Jiang L; Zhou Y; Pan H; Han W
Cancer Lett; 2016 Mar; 372(2):226-38. PubMed ID: 26803057
[TBL] [Abstract][Full Text] [Related]
25. Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.
Goessling W; Mayer RJ
Gastroenterol Clin North Am; 2006 Sep; 35(3):713-27. PubMed ID: 16952747
[TBL] [Abstract][Full Text] [Related]
26. Animal models of carcinogenesis in inflamed colorectum: potential use in chemoprevention study.
Tanaka T
Curr Drug Targets; 2012 Dec; 13(14):1689-97. PubMed ID: 23140280
[TBL] [Abstract][Full Text] [Related]
27. Autophagy modulation: a target for cancer treatment development.
Duffy A; Le J; Sausville E; Emadi A
Cancer Chemother Pharmacol; 2015 Mar; 75(3):439-47. PubMed ID: 25422156
[TBL] [Abstract][Full Text] [Related]
28. Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer.
Mazouffre C; Geyl S; Perraud A; Blondy S; Jauberteau MO; Mathonnet M; Verdier M
J Cell Mol Med; 2017 Oct; 21(10):2610-2622. PubMed ID: 28597984
[TBL] [Abstract][Full Text] [Related]
29. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
30. Effective targeting of colorectal cancer cells using TORC1/2 kinase inhibitors in vitro and in vivo.
Zhang J; Jiang W; Liu W; Wu JJ; Song L; Cheng JX; Yao M; Yang LP; Yao DF
Future Oncol; 2016 Feb; 12(4):515-24. PubMed ID: 26776341
[TBL] [Abstract][Full Text] [Related]
31. Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells.
Xiong L; Liu Z; Ouyang G; Lin L; Huang H; Kang H; Chen W; Miao X; Wen Y
Oncotarget; 2017 Jan; 8(4):6419-6432. PubMed ID: 28031534
[TBL] [Abstract][Full Text] [Related]
32. Autophagy regulation and its role in gastric cancer and colorectal cancer.
Zhou H; Yuan M; Yu Q; Zhou X; Min W; Gao D
Cancer Biomark; 2016 Jun; 17(1):1-10. PubMed ID: 27314289
[TBL] [Abstract][Full Text] [Related]
33. Cellular and Molecular Connections between Autophagy and Inflammation.
Lapaquette P; Guzzo J; Bretillon L; Bringer MA
Mediators Inflamm; 2015; 2015():398483. PubMed ID: 26221063
[TBL] [Abstract][Full Text] [Related]
34. Unravelling the pathogenesis of inflammatory bowel disease.
Xavier RJ; Podolsky DK
Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer.
Li H; Chen C
BMC Complement Altern Med; 2017 Dec; 17(1):538. PubMed ID: 29246220
[TBL] [Abstract][Full Text] [Related]
36. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.
Wei TT; Lin YT; Chen WS; Luo P; Lin YC; Shun CT; Lin YH; Chen JB; Chen NW; Fang JM; Wu MS; Yang KC; Chang LC; Tai KY; Liang JT; Chen CC
EBioMedicine; 2016 Aug; 10():124-36. PubMed ID: 27448759
[TBL] [Abstract][Full Text] [Related]
37. Principles and current strategies for targeting autophagy for cancer treatment.
Amaravadi RK; Lippincott-Schwartz J; Yin XM; Weiss WA; Takebe N; Timmer W; DiPaola RS; Lotze MT; White E
Clin Cancer Res; 2011 Feb; 17(4):654-66. PubMed ID: 21325294
[TBL] [Abstract][Full Text] [Related]
38. New Insights into Vitamin D and Autophagy in Inflammatory Bowel Diseases.
Suh HW; Kim JK; Kim TS; Jo EK
Curr Med Chem; 2017; 24(9):898-910. PubMed ID: 27915989
[TBL] [Abstract][Full Text] [Related]
39. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.
Chude CI; Amaravadi RK
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621712
[TBL] [Abstract][Full Text] [Related]
40. Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease.
Ke P; Shao BZ; Xu ZQ; Chen XW; Liu C
Front Immunol; 2016; 7():695. PubMed ID: 28119697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
